151 results on '"Muhlestein, Joseph B."'
Search Results
2. Abstract 14841: Higher Than Daily RDA Recommended Vitamin D3 Dosing and Multiple Titrations Are Required to Achieve >40 ng/mL 25-hydroxy Vitamin D Levels in Acute Coronary Syndrome (ACS) Participants Enrolled and Randomized to Targeted Vitamin D Treatment: The Target D Trial
3. Abstract 13308: Characteristics of Participants Enrolled in a Randomized Controlled Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events: The Target-D Trial
4. Abstract 12870: Absence of LDL Measurement in Secondary Prevention is Associated With Increased Subsequent Major Adverse Clinical Event (MACE) That is Only Partially Mitigated by Statin Use
5. Abstract 12122: Five-Year Serial Measurement of the Intermountain Mortality Risk Score for Population Health Assessment Reveals Personalized Temporal Trajectories of Differential Longevity Over Two Decades
6. Abstract 11652: What is the Relative Risk for Elevated Liver Function Tests of Single and Combined Statin and Alcohol Use and Implications for Management?
7. Abstract 11600: Characteristics and Outcomes of Statin Use During Pregnancy: A US Real-World Experience
8. Abstract 10842: Progression of COVID-19 Severity Among SARS-CoV-2 Positive Patients Prescribed Selective Serotonin Reuptake Inhibitors
9. Abstract 10714: Disparities in Cardiovascular Investigator-Initiated Research Studies
10. Abstract 10149: Clinical Predictors of Medical Therapy-Induced Improvement in Left Ventricular Function in Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HFrEF): The Intermountain Healthcare Experience
11. Abstract 10083: Cardiovascular Outcomes of Non-ST-Elevation Myocardial Infarction (NSTEMI) Patients Without Standard Modifiable Risk Factors (SMuRF-less): The Intermountain Healthcare Experience
12. Abstract 14841: Higher Than Daily RDA Recommended Vitamin D 3 Dosing and Multiple Titrations Are Required to Achieve >40 ng/mL 25-hydroxy Vitamin D Levels in Acute Coronary Syndrome (ACS) Participants Enrolled and Randomized to Targeted Vitamin D Treatment: The Target D Trial
13. Abstract 16802: Economics and Outcomes of Sotalol and Dofetilide In-Patient Dosing Approaches in Patients With Atrial Fibrillation
14. Abstract 16745: Effect of the Baseline Use of Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin-Receptor Blockers (ARBs) on Outcomes of Patients With Suspected or Positive COVID-19 Infection
15. Abstract 16681: Ability of the Intermountain Risk Score Measured in 2019 (pre-COVID) to Predict Major Adverse Health Events in Patients Positive for SARS-CoV-2 in 2020
16. Abstract 16587: More Than Five Years After FDA Approval, There Remains Very Limited Adoption of New Evidence-Based, Highly Effective Medications for the Treatment of Patients With Heart Failure, Especially Among Those on Medicare
17. Abstract 15941: Derivation of Risk-Scores That Stratify Risk of Hospitalization and Death in SARS-CoV-2 Positive Patients
18. Abstract 15875: Prediction of Intensive Care Unit Admission Among Patients Hospitalized for COVID-19: The Intermountain Coronavirus ICU Risk Model (CORONA-ICU)
19. Abstract 15389: Effect of Icosapent Ethyl on Changes in Coronary Plaque Characteristics at 9 Months in Patients With Elevated Triglycerides on Statin Therapy: Insights From EVAPORATE
20. Abstract 15317: Risk of Future Adverse Events in Patients Receiving Class IC Antiarrhythmic Drugs Who Have Elevated Coronary Artery Calcium Scores But Low-risk Cardiac Stress Test
21. Abstract 15094: In Patients on Warfarin, Does a History of Depression Impact Time in Therapeutic Range and Subsequent Dementia Risk?
22. Abstract 14840: Ability of Coronary Calcium Absence to Predict Negative Stress Test Results in Patients Considered for Flecainide Therapy
23. Abstract 14607: Randomized Controlled Trial of Once-Per-Week Intermittent Fasting for the Reduction of Low-Density Lipoprotein Cholesterol
24. Abstract 14134: The Impact of Ablation for Atrial Fibrillation on Dementia Incidence in Patients With and Without Depression
25. Abstract 13889: The Influence of Depression on Dementia Risk in Patients With Atrial Fibrillation
26. Abstract 13128: Development and Initial Utilization of a Multi-institutional Distributed Data Network Designed to Evaluate Real-world Clinical Outcomes in Patients Presenting for Percutaneous Coronary Intervention (PCI): Results From the Building the Unique Device Identifier (UDI) Into Longitudinal Data for Medical Device Evaluation (BUILD) Network
27. Abstract 13551: Identifying Left Main Coronary Artery Disease Using Coronary Artery Calcium Scans
28. Abstract 17437: No Significant Correlations Identified Between Carotid Intima-Media Thickness Measurements and Coronary Artery Calcium Scores or CT Coronary Angiography-Derived Plaque Compositional Characteristics in Asymptomatic Diabetic Patients
29. Abstract 16804: Proteins Desmin and VEGFR-1 are Associated With Coronary Calcium Scores in Diabetic Patients Without Prior Cardiovascular Disease: A Proteomic Analysis of Factor64 Clinical Trial Subjects
30. Abstract 16743: Muscle Skeletal Receptor Tyrosine-Protein Kinase (MuSK) is Associated With Low Density Lipoprotein Levels in Diabetic Patients on Statins Without Prior Cardiovascular Disease: A Proteomic Analysis of FACTOR-64 Clinical Trial Subjects
31. Abstract 16574: Association Between Visit-to-Visit Variability of Systolic Blood Pressure and All-Cause Mortality
32. Abstract 16095: Treatment Gap of Statin Therapy in Patients Hospitalized With a New Diagnosis of Atherosclerotic Cardiovascular Disease (ASCVD) Within a Large Integrated Healthcare Institution: The IMPRES Study
33. Abstract 16086: Impact of Statin Prescription and Intensity at Discharge After an Atherosclerotic Cardiovascular Event (ASCVD)—Real-World Experience in a Large Integrated Healthcare System: The IMPRES Study
34. Abstract 16041: Interaction of Genetic Variation at the ABO Locus With Short-Term Exposure to Elevated Fine Particulate Matter Air Pollution Results in Differential Associations With Acute Coronary Events
35. Abstract 15950: Predictors of Statin Intolerance in Patients With a New Diagnosis of Atherosclerotic Cardiovascular Disease (ASCVD) Within a Large Integrated Healthcare Institution: The IMPRES Study
36. Abstract 15545: Long-term Impact of a Hospital-based Discharge Medication Program Designed to Assure Appropriate Utilization of Statin Therapy in Patients Hospitalized With a New Diagnosis of Coronary Artery Disease (CAD) Within a Large Integrated Healthcare Institution: A Significant Treatment Gap Still Remains: The IMPRES Study
37. Abstract 15431: Absence of LDL Measurement After an Atherosclerotic Cardiovascular Disease (ASCVD) Event Increases the Incidence of a Subsequent Major Adverse Clinical Event (MACE)-Real World Experience in a Large Integrated Healthcare System: The IMPRES Study
38. Abstract 10356: Impact of Statin Therapy in Heart Failure Patients: Results of a Large Real-World Experience
39. Abstract 11190: Impact of the Use of Platelet Function Testing to Guide P2Y12 Inhibitor Usage After Percutaneous Coronary Intervention (PCI): Results of a Large Real-World Experience
40. Abstract 11815: Statin Intolerance is Predicted by Intolerance to Multiple Others Drugs: Results of a Large Real-World Experience
41. Abstract 11396: A Small but Significant Increased Incidence of Acute Pericarditis Identified After Vaccination for SARS-CoV-2
42. Abstract 10330: Intermittent Fasting Interacts with Red Cell Distribution Width to Differentially Improve Cardiometabolic Health
43. Abstract 12306: Impact of the COVID Pandemic on Depression and Subsequent Emergency Department Visits for Anxiety and Chest Pain
44. Abstract 12457: Atrial Fibrillation is a Cardiovascular Risk Factor for Worse Prognosis in COVID-19
45. Abstract 10312: Intermittent Fasting and Increased Galectin-3 Reveal a Potential Protective Mechanism Against Risk of Heart Failure and Type 2 Diabetes
46. Abstract 11605: Analysis of 10-yr MACE Risk of LDL-C ≥160-189 Mg/dL Compared to <160 Mg/dL in Young Adults (ages 20-39) in an Integrated Healthcare System
47. Abstract 10363: Mitochondrial DNA Copy Number is Associated with Severe Coronary Artery Disease and Risk of Subsequent Long-Term Major Adverse Cardiovascular Events
48. Abstract 12443: Incident Heart Failure Risk After Acute Myocardial Infarction is Stratified by the Intermountain Major Adverse Cardiovascular Events (IMACE) Risk Scores
49. Abstract 12529: The Association of the Different Vitamin D Metabolites to Death, Myocardial Infarction, Heart Failure, and Stroke: Results From the Intermountain Heart Collaborative Study
50. Abstract 12215: Objective Stratification of Six-Month Mortality Risk among Patients Referred to Hospice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.